Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in RECURSION PHARMACEUTICALS IN
BNP PARIBAS FINANCIAL MARKETS holds 1.1M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $4.4M as of 2025-Q4. The position was increased (++858.4% shares). RXRX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$4.4M
Current Shares
1.1M
Total Value Change
+$4.2M
Total Shares Change
+1M
Other major holders of RXRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BAILLIE GIFFORD & CO
Increased |
| 1.1M |
+858.4% |
| $4.4M |
| 0.0% |
| $4.11 |
43 |
| 2025-Q3 | Decreased | 113,125 | -1.4% | $552,050 | 0.0% | $4.91 | 0 |
| 2025-Q2 | Increased | 114,795 | +522.7% | $580,863 | 0.0% | $5.03 | 39 |
| 2025-Q1 | Decreased | 18,435 | -46.6% | $97,521 | 0.0% | $5.81 | 0 |
| 2024-Q4 | New | 34,504 | - | $233,247 | 0.0% | $6.77 | 32 |